文献速递静脉血栓栓塞慢性静脉疾病

急性髂股深静脉血栓合并May-Thurner综合征的门诊管理初探:经皮机械取栓、血管成形术与支架置入

Initial experience with the ambulatory management of acute iliofemoral deep vein thrombosis with May-Thurner syndrome with percutaneous mechanical thrombectomy, angioplasty and stenting.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-03-19

本研究回顾性分析2020年1月至2022年10月因急性髂股深静脉血栓合并May-Thurner综合征接受介入治疗的92例患者,分为住院组58例和门诊组34例,所有患者均接受经皮机械取栓、血管内超声、血管成形术和支架置入,技术成功率100%。住院组3例需辅助溶栓,两组12个月原发通畅率无显著差异(住院组73.5% vs 门诊组86.7%,P=.21)。作者认为,对该类患者可启动门诊直接口服抗凝药治疗并后续行门诊经皮机械取栓、血管成形术和支架置入。

要点

  • 92例急性髂股深静脉血栓合并May-Thurner综合征患者接受经皮机械取栓、血管成形术和支架置入,技术成功率100%。
  • 住院组58例,门诊组34例;住院组3例需辅助溶栓。
  • 12个月原发通畅率住院组73.5% vs 门诊组86.7%,无显著差异(P=.21)。

核心结论

  • 作者认为,对适合取栓和髂静脉血运重建的急性髂股深静脉血栓合并May-Thurner综合征患者,可启动门诊直接口服抗凝药治疗并后续返回行门诊经皮机械取栓、血管成形术和支架置入。

研究设计与样本

  • 回顾性分析2020年1月至2022年10月因急性髂股深静脉血栓合并May-Thurner综合征接受单侧取栓、静脉血管成形术和支架置入的患者,分为住院组和门诊组,比较人口学特征、危险因素、手术成功、并发症和随访。

主要发现

  • 共92例患者接受取栓、血管成形术和支架置入,其中住院组58例,门诊组34例。
  • 全部92例均使用Inari ClotTriever行经皮机械取栓、血管内超声、血管成形术和支架置入,技术成功率100%。
  • 住院组3例需辅助溶栓。
  • 12个月原发通畅率住院组73.5% vs 门诊组86.7%,无显著差异(P=.21,log-rank检验)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients undergoing intervention for acute iliofemoral deep vein thrombosis (IFDVT) with May-Thurner syndrome (MTS) typically require inpatient (IP) hospitalization for initial treatment with anticoagulation and management with pharmacomechanical thrombectomy. Direct oral anticoagulants and percutaneous mechanical thrombectomy (PMT) devices offer the opportunity for outpatient (OP) management. We describe our approach with these patients. METHODS: Patients receiving intervention for acute IFDVT from January 2020 through October 2022 were retrospectively reviewed. Patients undergoing unilateral thrombectomy, venous angioplasty, and stenting for IFDVT with MTS comprised the study population and were divided into two groups: (1) patients admitted to the hospital and treated as IPs and (2) patients who underwent therapy as OPs. The two groups were compared regarding demographics, risk factors, procedural success, complications, and follow-up. RESULTS: A total of 92 patients were treated for IFDVT with thrombectomy, angioplasty, and stenting of whom 58 comprised the IP group and 34 the OP group. All 92 patients underwent PMT using the Inari ClotTriever (Inari Medical), intravascular ultrasound, angioplasty, and stenting with 100% technical success. Three patients in the IP group required adjuvant thrombolysis. There was no difference in primary patency of the treated IFDVT segment at 12 months between the two groups (IP, 73.5%; OP, 86.7%; P = .21, log-rank test). CONCLUSIONS: Patients with acute IFDVT and MTS deemed appropriate for thrombectomy and iliac revascularization can be managed with initiation of ambulatory direct oral anticoagulant therapy and subsequent return for ambulatory PMT, angioplasty, and stenting. This approach avoids the expense of IP care and allows for effective use of resources at a time when staffing and supply chain shortages have led to inefficiencies in the provision of IP care for nonemergent conditions.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Nguyen D, Berman SS, Balderman JA, et al. Initial experience with the ambulatory management of acute iliofemoral deep vein thrombosis with May-Thurner syndrome with percutaneous mechanical thrombectomy, angioplasty and stenting. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38513797. doi:10.1016/j.jvsv.2024.101875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。